Brief: Collegium Pharmaceutical Q2 Revenue USD 135.5 Million Vs. IBES Estimate USD 138.4 Million
03/08/2023 21:01
Aug 03 (Reuters) - Collegium Pharmaceutical Q2 net income USD 13 million. * Q2 adjusted EBITDA USD 85.8 million
Recent news on Collegium Pharmaceutical
See all newsBrief: Collegium Pharmaceutical - Co And Grünenthal Enter Settlement Agreement On Oct 15, 2026 - SEC Filing
Brief: Collegium Announces $50 Million Accelerated Share Repurchase Program
U.S. RESEARCH ROUNDUP-Airbnb, Expedia Group, Parker-Hannifin
Collegium Pharmaceutical Inc reports results for the quarter ended June 30 - Earnings Summary
Collegium Q2 revenue rises 6%